Business Wire › February 03, 2006
Linked as:Extract
ABIOMED Announces Expanded Reimbursement and Distribution in Europe for IMPELLA RECOVER(R) Circulatory Support Systems; Expected to Fuel Increased Utilization of ABIOMED Recovery Solutions in Largest European Markets.
DANVERS, Mass. -- ABIOMED, Inc. (NASDAQ: ABMD) today announced that the governmental authority for reimbursement in Germany (InEK) has granted the highest approval level available for ABIOMED's IMPELLA(R) RECOVER(R) Devices. The new German reimbursement standard will apply to ABIOMED's IMPELLA Recover(R) ...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
cbre lands first retail lease at saddle brook s skyview. | Research and Markets: Research and Development on Crohn's Disease & Ulcerative Colitis. | national gypsum introduces sound-reducing gypsum board. | Active membership. | decisión nº si-042-07 de tribunal séptimo de juicio de zulia (extensión maracaibo), de october ... | Decisión de Juzgado Primero de Primera Instancia en lo Civil, Mercantil y Transito Los T... | decisión de juzgado segundo ejecutor de medidas de los municipios mariño, garcia maneiro,... | Decisión nº 943-06.- de Tribunal Cuarto de Control de Zulia (Extensión Maracaibo), de April 21, 2006
